HALOZYME THERAPEUTICS, INC. (HALO) Stock Profile — Insider Trades & Financials

Revenue$451.8M

Net Income-$141.6M

EPS$2.56

Market Cap$7.5B

Price Performance

Historical data including institutional events

Loading price data...

Helen Torley

CEO & Executive Director

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.

Peer ComparisonRevenue ($B)

▾

⚡

ROE?

-290.06%

ROA?

-5.61%

D/E Ratio?

50.73

Op. Margin?

-20.56%

📊

Net Margin?

-31.34%

Loading company sections...